SIRT1, an NAD+-dependent class III histone deacetylase, is deemed to be responsible for the beneficial effects in the development and treatment of cardiovascular diseases (D'Onofrio et al., 2018; Kane and Sinclair 2018). This evidence concerns the gene SIRT1 and cardiovascular disorder.